Reliable detection of somatic variants from next-generation sequencing data requires the ability to 16 effectively handle a broad range of diverse conditions such as aneuploidy, clonality, and purity of 17 the input tumor material. The sensitivity and specificity of any somatic mutation calling approach 18 varies along the genome due to differences in sequencing read depths, error rates, mutation types 19
and their sizes (e.g., SNVs, indels, CNVs). Micro-assembly approaches 1 have been successful at 20 calling indels up to a few hundred base pairs in length, allowing inquiry into the twilight zone 21 between longer indels and shorter CNVs. However, existing micro-assembly methods rely on 22 separate assembly of tumor and matched normal data, which has limitations in regions with low 23 supporting coverage, repeats, and large indels. Accounting for these variables requires flexible 24 methods that can adapt to the specific context of each genomic region. 25
We here introduce a new somatic SNV and indel caller, Lancet, which uses localized colored 26 DeBruijn graphs (Fig. 1) to detect somatic variants with high accuracy in paired tumor and normal 27 samples. Lancet builds upon the effective assembly engine we introduced in the Scalpel 2 variant 28 caller, that localizes the assembly to small genomic regions. However, unlike Scalpel, Lancet 29 jointly assembles reads from a tumor and a matched normal sample into colored DeBruijn graphs 30 that are automatically optimized according to the repeat composition of each sequence 31 ( Supplementary Fig. 1 and Online Methods). The colored DeBruijn graph assembly paradigm 32 was initially introduced and applied to detection and genotyping of both simple and complex 33 germline variants in a single individual or population 3 . We here demonstrate that this paradigm is 34 even more powerful in the context of somatic variant detection. Unlike the initial work of Iqbal et 35 al.,  where the colored DeBruijn graph is constructed for the whole genome, Lancet builds a local 36 colored DeBruijn graph in a short genomic region (default 600bp) following the micro-assembly 37 paradigm 1, 2 . The local assembly paradigm makes a very detailed analysis of the graph structure 38 computationally tractable, allowing the detection of low frequency mutations private to the tumor 39 without sacrificing the sensitivity to call longer mutations. In the Lancet framework, somatic 40 variants correspond to simple paths in the graph whose nodes (k-mers) belong only to the tumor. 41
Partially supported variants in the normal sample can be easily detected and classified as germline 42 variants ( Supplementary Fig. 2 ). Among its many features, Lancet employs: 1) an Edmonds-Karp 43 style network-flow algorithm to efficiently enumerate all haplotypes in a genomic region; 2) on-44 the-fly short tandem repeat (STR) analysis of the sequence context around each variant; 3) a highly 45 reliable scoring system; 4) carefully tuned filters to prioritize higher confidence somatic variants; 46 and 5) a simple and efficient active region module to skip the analysis of genomic regions with no 47 evidence of variation; (Online Methods). Finally, in additional to running the tool in discovery 48 mode, Lancet can be used interactively for an in-depth analysis of a region of interest, similarly to 49 other bioinformatics utilities used for operating on BAM files, such as samtools 4 , bamtools 5 , 50 bedtools 6 , etc. Colored DeBruijn graphs can be easily exported and rendered to visualize variants 51 of interest in graph space ( Fig. 1) , which can help in confirming a variant. This feature 52 complements read alignment visualization tools such as the Integrative Genomics Viewer (IGV) 7 53
and provides another useful view into the data that supports variant calling. 54 55 Figure 1. Colored DeBruijn illustration. Example of colored DeBruijn graph for a short region of 400bp containing 56 an insertion. Blue nodes correspond to k-mers shared by both the tumor and the normal samples also matching the 57 reference sequence, red nodes correspond to k-mers private to the tumor, green nodes correspond to k-mers private to 58 the normal, and white nodes correspond to low coverage k-mers due to sequencing errors.
59
We performed extensive experimental comparisons using several synthetic and real-world datasets 60 designed to assess the variant calling abilities of Lancet under diverse tumor clonality/cellularity 61 and sequencing conditions on a range of Illumina platforms (HiSeq 2000, HiSeq 2500, HiSeq X) 62
commonly used for whole-genome sequencing. We compared Lancet to some of the most widely 63 
80
Virtual tumors. Using a strategy similar to the one described in the MuTect paper 8 , we generated 81 virtual tumors by introducing reads that support real germline SNVs and indels in HapMap sample 82 NA12892, from an unrelated HapMap sample NA12892, both sequenced on the Illumina HiSeq X 83 system. Only actual sequencing data was used to spike-in somatic variants at a ladder of variant 84 allele fractions at variable loci identified in those sample as part of the 1000 Genomes Project 85
( Supplementary Fig. 3 and Online Methods). By knowing the true somatic variants and 86 controlling the VAF of inserted mutations, we use the virtual tumors to test the methods' ability to 87 callers analyzed in this study on this dataset, especially for indels ( Fig. 2a-b ). On this dataset, 90
Lancet behaves close to an (ideal) variant caller that makes no errors (straight line with 91 precision=1) demonstrating a highly reliable scoring system for both SNVs and indels. The other 92 tools tend to either introduce errors early by assigning high scores to false positive variants or 93 substantially worsen in precision at higher recall rates. Although the truth set contains a handful of 94 somatic STR mutations ( Supplementary Fig. 4 ), analysis of indels called by each tool shows 95
higher false positive rate of somatic STR indels for Strelka2, LoFreq, and MuTect2 compared to 96
Lancet and Strelka (Supplementary Fig. 5 ). When calling indels, Lancet and Strelka2 demonstrate 97 higher sensitivity ( Supplementary Fig. 6a ) in particular for variants with VAF < 10% ( Fig. 2d) , 98
however Lancet loses the least amount of precision compared to the other tools ( Fig. 2b) . All the 99 callers show similar performance in the detection of indels with VAF>10%, with the exception of 100
Strelka, whose sensitivity for indels is comparable to the other methods only at 20% VAF or 101
above. With the exception of LoFreq, all the tools show similar sensitivity to detect SNVs across 102 the VAF spectrum ( Fig. 2c) , however Lancet's superior accuracy is highlighted in the 103 precision/recall curve ( Fig. 2a) . Finally, Lancet produces by far the best overall F 1 -score across all 104 the tested methods on the virtual tumor for indel calling (Tables 1 and 2) . Lancet and Strelka2 105 achieve the same F 1 -score on SNVs calling, however Lancet generates half the number of false 106 positives compared to Strelka2. Analysis of the reference and alternative allele counts shows great 107 variability in the number of supporting reads for each tool, due to the different methods and filters 108 used in selecting the reads. As expected, most false positive indels have few reads containing the 109 alternative allele; this is largely the case for Lancet, while other tools (e.g., MuTect2), report a 110 number of false positives indels with high support for the alternative allele, indicating a problem in 111 estimating the correct variant allele fraction ( Supplementary Fig. 7) . Strelka has the lowest 112 number of false positive calls but the distribution of supporting reads highlights its limited power 113 in detecting indels with very low support. 114 
121
Synthetic tumors. We performed an additional comparison using the synthetic tumors from the 122 ICGC-TCGA DREAM mutation calling challenge #4. This dataset was the most difficult to 123 analyze due to a combination of complex clonality and cellularity of the tumor sample, which 124 contained two sub-clones of 30% and 15% allelic fraction. We discovered that the truth set for this 125
dataset contains many variants with supporting reads coming only from one strand (thus 126 introducing a strong strand bias), and for this experiment we turned off Lancet's strand bias filter. 127
In real tumors, such strong strand bias is unlikely to happen. Precision/recall curve analysis 128 ( Supplementary Fig. 8 ) together with the precision, FDR, and F 1 -score values ( Supplementary  129 Tables 1 and 2) show that on this dataset Lancet outperforms all other somatic callers for indel 130 calling and is comparable to MuTect2, the best performing method, for SNV calling. Strelka2 131
shows an impressive precision/recall curve for SNVs up to 0.6 recall, however its precision drops 132 considerably afterwards. As reported in previous studies 2, 15 , assembly based methods, such as 133
Lancet and MuTect2, demonstrate substantially more power to detect indels of 50 base pairs or 134 longer compared to alignment-based methods (Supplementary Fig. 9 ). Exception to this rule is 135
Strelka2 which still shows limited power to detect larger indels despite the use of an assembly-136 based procedure in its haplotype generation step. Analysis of the size distribution of called variants 137
shows that both MuTect2 and LoFreq have strong bias towards calling longer false positive indels 138 (Supplementary Fig. 10) . 139
Normal tissue/tumor pair. We next analyzed real data from a case of medulloblastoma used in 140 the cross-centers benchmarking exercise of the International Cancer Genome Consortium 141 (ICGC) 13 . Unlike the synthetic tumors of the ICGC-TCGA DREAM mutation calling challenge, no 142 single mutation was spiked-in, but rather a curated list of somatic mutations (SNVs and indels) was 143 compiled (the Gold Set). Due to the heterogeneity of the raw data (multiple library protocols, 144
Illumina sequencers, read lengths, and fragment sizes), this dataset is particularly noisy and 145 challenging to analyze. Moreover, differently from the previous datasets used in this study, the 146 majority of indel calls contained in the Gold Set are located within STRs (Supplementary Fig.  147  12a) . Variant calling accuracy of all tools is generally inferior in comparison to the previous 148 benchmarking experiments (Supplementary Fig. 11 ) but final precision and recall values are in 149 agreement with the results reported by the ICGC benchmarking team. Strelka2 and LoFreq have 150 better precison/recall curves for indels up to 0.5 recall, but Lancet shows the best final trade-off 151 between precision and recall (F 1 -score) and it ranks second in SNV detection, after LoFreq 152 ( Supplementary Tables 3 and 4) . Although LoFreq and Strelka2 have higher indel recall rates 153 ( Supplementary Tables 3 and Supplementary Fig. 12b) , their final precision is substantially 154 lower compared to Lancet and LoFreq (Supplementary Fig. 12c) , indicating that these tools may 155
have difficulties in handling the noise in the data. Inspection of the F 1 -score values, as a function of 156 recall, shows all callers favor sensitivity over specificity in this dataset (Supplementary Fig. 13 ) -157 indicating that they have likely been optimized for higher quality data. As is the case with virtual 158 tumors, false positive indels within STRs are highly discordant across callers in the 159 medulloblastoma dataset (Supplementary Fig. 12c-d) , thus confirming an overall lower quality of 160 these calls. In contrast, Lancet reports a very small number of false positive indels without losing 161 sensitivity (Supplementary Fig. 12b-c) . 162
Normal tissue/primary tumor/metastasis trio. Finally, we analyzed a pair of highly genetically 163 concordant primary and metastatic cancer lesions to check the robustness of different methods to 164 identify shared and private somatic mutations. Concordance of SNVs shared between the primary 165 and metastasis is much higher compared to indels among the analyzed tools, however higher 166 agreement of the called indels is achieved when indels within STRs are removed ( Supplementary  167  Fig. 14) . These results once more highlight the problem of detecting somatic STRs and emphasize 168 the challenging but necessary task of integrating indel calls across different methods. 169
We discovered that the major source of disagreement between callers originates from variants 170 called within STRs, in particular if the motif is two base pairs or longer (Supplementary Fig. 5 ).
171
Venn diagrams of the false positive somatic STR calls in the virtual tumor dataset shows that the 172 callers highly disagree (Supplementary Fig. 6b ). Since the virtual tumors were created by 173
partitioning the raw reads from a single real sample, the erroneous STR indels are the results of 174
higher replication slippage at those sites that the tools misclassify as somatic events. Lancet 175 instead, thanks to a more precise scoring and filtering systems and the employment of the colored 176
DeBruijn graph, makes less errors at STR sites. Alignment based tools, such as LoFreq, are 177
inherently more prone to misclassify longer variants as somatic. IGV inspection of a putative 178 subset of LoFreq calls on the ICGC-TCGA DREAM data highlights that the false positive indels 179 are typically due to mis-alignment of the supporting reads in the normal (Supplementary Fig. 15 ).
180
Most of the MuTect2 false positive insertions for the same dataset correspond to breakpoints of 181 larger structural variants that are misinterpreted as small insertions (Supplementary Fig. 16-17) . 182
The key novel feature introduced by Lancet, is the usage of colored DeBruijn graphs to jointly 183 analyze tumor and normal reads. This strategy substantially increases the accuracy of identifying 184 mutations, especially indels, private to the tumor. Precision/recall curve analysis demonstrates that 185
Lancet has a reliable variant quality scoring system, which is critical for prioritizing somatic 186 variants. Lancet shows high precision when calling somatic mutations, even at STR sites, and 187 provides robust calls across data generated by different Illumina sequencers. Due to its pure local-188 assembly strategy, Lancet currently has longer runtimes compared to alignment based methods, 189
which is an area we plan to improve upon in the future releases of the tool. In addition to being 190 used as a genome-wide analysis tool, Lancet can be used interactively to call variants and render 191 colored DeBruijn graphs at small genomic regions of interest. Our extensive comparative analysis 192 also indicates that somatic callers are now optimized for higher quality data, although inspection of 193 the max F 1 -score values suggests that better performance is achievable on noisy data with more 194 stringent quality cutoffs. Given all the new features, we anticipate Lancet to become an invaluable 195 resource for the bioinformatics community working on cancer. 196 to identify reads which are highly likely to be multi-mapped (|AS-XS| £ d where d =5). If BWA-232 ALN is employed, multi-mapped reads are marked using the XT:Z::R tag, nonetheless, their 233 mapping quality is not necessarily zero. This is because mapping quality is computed for the read 234 pair, while XT is only determined from a single read. For example, when the mate of a read can be 235 mapped unambiguously, the read can still be mapped confidently and thus assigned a high 236 mapping quality. In addition to the XT tag, multi-mapped reads are also identified using the XA 237 tag which is used to list the alternative hits of the read across the genome. Finally, to maximize the 238 sensitivity to detect variants that are also present in the normal sample, no filter is applied when 239
extracting the aligned reads. 240
Colored DeBruijn graph construction. The key data structure used by Lancet is the colored 241
DeBruijn graph constructed using the reads from both the tumor and the matched normal samples. 242 Fig. 1 shows an example of the DeBruijn graphs generated by Lancet. Formally the graph is 243 defined as G (V, E, C) where V is the set of vertices/nodes corresponding to the different k-mers 244 extracted from the reads, E is the set of edges connecting two nodes having a k-1 perfect match 245
between their respective k-mers, and C is the coloring scheme (labels) used to indicate whether the 246 k-mer has been extracted from the tumor or normal sample. To account for the double-strandedness 247 of DNA, Lancet constructs a bi-directed DeBruijn graph where each node stores both forward and 248 reverse complement of each k-mer. The graph is augmented with ancillary information extracted 249 from the raw sequencing data, specifically each node stores (i) the k-mer counts split by strand, (ii) 250
the list of reads where the k-mers were found, and (iii) the Phred quality for each base. The k-mers 251 from the reference sequence are also extracted and incorporated into the graph. Sequencing data is 252 typically generated from short-insert paired-end DNA libraries and the variable fragment size 253 distribution can sometimes cause two paired reads to overlap each other. Therefore, coverage 254 needs to be adjusted to avoid over counting the overlapping portion of the two reads. This is easyly 255 accomplished in the DeBruijn graph framework since k-mers extracted from the overlapping 256 segment come from reads that share the same query template (QNAME) in the BAM file. If this 257 condition is detected, the k-mer count is adjusted to only include one copy of the two k-mers. 258
Graph cleanup. Sequencing errors, coverage fluctuations, and mapping errors increase the graph 259 complexity by introducing nodes and edges that confound the analysis. Lancet utilizes several 260 graph operations and transformations designed to remove spurious nodes and edges introduced 261 during graph construction. First, low-coverage nodes, which are typically associated with 262 sequencing errors, are removed if the corresponding k-mer count is below a specific user defined 263 threshold (default 1) or if the coverage ratio is below a certain user defined value (default 0.01). 264
Second, dead-ends are removed, which present themselves as a sequence of uniquely linked nodes 265 that do not connect back to the graph (also called short tips). Dead-ends formed by n (default 11) 266 or more nodes are removed from the graph. Next short-links are removed, which are short 267 connections composed by fewer nodes than theoretically possible given the k-mer value used to 268 build the graph. Supplementary Fig. 18 illustrates one exemplary short-link scenario. This type of 269 connection is typically due to sequence homology between closely located repeats (e.g., Alu 270 repeats), but it can also happen in the case of long homopolymers, and other short tandem repeats, 271
where the tandem repetition of the motif can result in the construction of a tiny bubble in the 272 presence of a heterozygous mutation. Those tiny bubbles need to be kept in the graph as they may 273 represent true variation, while short-links like the one depicted in Supplementary Fig. 18 can be 274 safely removed. Therefore, connections at non-STR sites formed by m (<< k) or less nodes and 275 whose minimum coverage node is c < Öc avg are removed from the graph, where c avg is the average 276 coverage across the window. Finally, the graph is compressed by merging chains of uniquely 277 linked nodes into super nodes. 278
Repeat analysis. Small scale repeats are a major challenge for accurate variant calling, specifically 279 for indels 1 . To avoid introducing errors at those loci, Lancet employs the same repeat analysis 280 procedure introduced in the Scalpel algorithm. Specifically, the sequence composition in each 281 window is analyzed for the presence of perfect or near-perfect repeats (up to a specified number of 282 mismatches, 2 by default) of size k. Similarly, the graph is inspected for the presence of cycles 283 (perfect repeats) or near-perfect repeats in any of the source-to-sink paths. If a repeat structure is 284 detected, a larger k-mer value is selected and the repeat analysis is performed again on both the 285 reference sequence and the newly constructed graph, until a repeat-free graph is constructed or the 286 k-mer size has reached a maximum value (101 by default). To avoid using k-mers which are 287 reverse complement of their own sequences, only odd values of k are used to build the graph. This 288 iterative strategy is a key feature of the Lancet algorithm which automatically selects the optimal k-289 mer size according to the sequence composition of each genomic window. 290 Paths enumeration. Enumerating all possible haplotypes can take time, growing exponentially 291
with the number of bubbles present in the graph. To reduce the computational requirements of the 292 graph traversal down to polynomial time, we employ an Edmonds-Karp style algorithm for fast 293 enumeration of all possible haplotypes. The idea behind the algorithm is to find the minimum 294 number of paths from source to sink that cover every edge in the graph (edge and nodes can be 295 visited more than once). The pseudo code of the algorithm is presented below. Since every node is 296 visited (possibly multiple times), it is easy to show that, although the same variant could be 297 discovered multiple times, no variant is missed from the analysis. Straightforward complexity 298
analysis of the pseudocode shows that the worst case time complexity is O(E 2 +EV): at least one 299 edge is visited at each iteration (step 5) accounting for O(E) time, and each call to the graph 300
